Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors?

Liting Wang, Rodolphe Fischmeister, Boris Manoury

Open source

DOI
10.3390/cells14211670
Published
2025-10-25
Container
Cells
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cells14211670,
  title = {Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors?},
  author = {Liting Wang and Rodolphe Fischmeister and Boris Manoury},
  year = {2025},
  journal = {Cells},
  doi = {10.3390/cells14211670},
  url = {https://doi.org/10.3390/cells14211670}
}

RIS

TY  - JOUR
TI  - Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors?
AU  - Liting Wang
AU  - Rodolphe Fischmeister
AU  - Boris Manoury
PY  - 2025
JO  - Cells
DO  - 10.3390/cells14211670
UR  - https://doi.org/10.3390/cells14211670
ER  - 

APA

Wang, L., Fischmeister, R., & Manoury, B. (2025). Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors?. Cells. https://doi.org/10.3390/cells14211670

Source records